<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03448029</url>
  </required_header>
  <id_info>
    <org_study_id>RECCORD</org_study_id>
    <secondary_id>DRKS00013585</secondary_id>
    <secondary_id>U1111-1209-6562</secondary_id>
    <nct_id>NCT03448029</nct_id>
  </id_info>
  <brief_title>RECCORD (Recording Courses of Vascular Diseases) Registry</brief_title>
  <acronym>RECCORD</acronym>
  <official_title>RECCORD - Recording Courses of Vascular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emil GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RECording COurses of vasculaR Diseases registry (RECCORD registry) is an observational,
      prospective, multicentre, all-comers registry platform.

      In the initial phase, patients referred for endovascular revascularization of peripheral
      artery disease (PAD) of the lower limbs will be prospectively included and followed up for at
      least one year.

      At baseline, data on patients' demographic characteristics, comorbidities, previous
      peripheral interventions, medication, and clinical stage of PAD (Rutherford category),
      haemodynamic parameters, and procedural data including complications will be assessed.

      Major adverse cardiac and limb events will be recorded at planned (at six and 12 months) and
      at any unplanned visits.

      For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR
      Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR
      Diseases registry (RECCORD registry). Vasa.

      https://doi.org/10.1024/0301-1526/a000631
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Outcome Quality after Revascularization: Complications</measure>
    <time_frame>Up to 1 month</time_frame>
    <description>Peri- and post-interventional complications (puncture-site complications &amp; intervention-related complications over 30 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome Quality after Revascularization: Amputation</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Amputation-free survival (AFS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome Quality after Revascularization: Survival</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Survival at one year in CLI patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life: EQ-5D-5L questionnaire</measure>
    <time_frame>At baseline, at 6 and 12 months</time_frame>
    <description>EQ-5D-5L questionnaire to asses patient's health state and patient's self-rated health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome Quality after Revascularization: Re-Intervention</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Number of re-interventions</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Vascular Diseases</condition>
  <condition>Peripheral Artery Disease</condition>
  <condition>Claudication</condition>
  <condition>Critical Limb Ischemia</condition>
  <condition>Diabetic Foot</condition>
  <arm_group>
    <arm_group_label>Endovascular Patients</arm_group_label>
    <description>Patients undergoing endovascular interventions for symptomatic PAD</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing endovascular revascularization for symptomatic peripheral artery
        disease of the lower extremities (located distal to the aorto-iliac bifurcation) will be
        included. The diagnosis of PAD will be derived from ICD-10 codes. Any endovascular
        procedure that is performed to a specifi c target lesion will be documented as operation
        and procedure codes (OPS codes) as they are defi ned by the German procedure classifi
        cation system (version 2015). Informed consent from each patient will be obtained prior to
        inclusion in the registry.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any type of endovascular interventions for symptomatic PAD

          -  endovascular intervention for PAD of lower extremities, i.e. below the aorto-iliac
             bifurcation

        Exclusion Criteria:

          -  patients undergoing hybrid-(surgical and endovascular) and/or surgical interventions
             for symptomatic PAD

          -  patients with a life expectancy of &lt;6 months

          -  endovascular intervention for reasons other than symptomatic PAD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marco Tränkle</last_name>
    <phone>0049-761-4589480</phone>
    <email>info@reccord.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcus Treitl, Prof.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Erbel, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SRH Klinikum Karlsbad-Langensteinbach</name>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Württemberg</state>
        <zip>76307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erwin Blessing, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Immenstadt</name>
      <address>
        <city>Immenstadt Im Allgäu</city>
        <state>Bayern</state>
        <zip>87509</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wulf Ito, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Ludwig-Maximilians Universität</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Treitl, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <state>Nordrhein-Wesfalen</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohammad Nasser Malyar, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Königin Elisabeth Herzberge gGmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10365</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Stegemann, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sankt Gertrauden-Krankenhaus</name>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Langhoff, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://econtent.hogrefe.com/doi/pdf/10.1024/0301-1526/a000631</url>
    <description>Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry), Vasa (2017), 46, pp. 262-267</description>
  </link>
  <link>
    <url>https://www.reccord.de</url>
    <description>Official RECCORD Homepage</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2018</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vascular Diseases</keyword>
  <keyword>Peripheral Artery Disease</keyword>
  <keyword>Revascularisation</keyword>
  <keyword>Outcome</keyword>
  <keyword>Quality Management</keyword>
  <keyword>Registry</keyword>
  <keyword>Endovascular Intervention</keyword>
  <keyword>Limb Amputation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

